Galectin-8-IN-2, with the CAS number 1044566-24-6, is a small molecule inhibitor specifically targeting galectin-8, a member of the galectin family of proteins that play crucial roles in various biological processes, including cell adhesion, immune response, and tumor progression. This compound is characterized by its ability to modulate galectin-8 activity, which can influence cellular interactions and signaling pathways. Typically, such inhibitors are studied for their potential therapeutic applications in cancer and inflammatory diseases, as galectins are often implicated in tumor metastasis and immune evasion. The molecular structure of Galectin-8-IN-2 includes specific functional groups that enhance its binding affinity to the galectin-8 protein, making it a valuable tool in biochemical research and drug development. As with many small molecule inhibitors, its efficacy and specificity are critical parameters that are evaluated through various in vitro and in vivo studies. Overall, Galectin-8-IN-2 represents a promising avenue for therapeutic intervention in diseases where galectin-8 is a contributing factor.

Galectin-8-IN-2

1044566-24-6: Galectin-8-IN-2, with the CAS number 1044566-24-6, is a small molecule inhibitor specifically targeting galectin-8, a member of the galectin family of proteins that play crucial roles in various biological processes, including cell adhesion, immune response, and tumor progression. This compound is characterized by its ability to modulate galectin-8 activity, which can influence cellular interactions and signaling pathways. Typically, such inhibitors are studied for their potential therapeutic applications in cancer and inflammatory diseases, as galectins are often implicated in tumor metastasis and immune evasion. The molecular structure of Galectin-8-IN-2 includes specific functional groups that enhance its binding affinity to the galectin-8 protein, making it a valuable tool in biochemical research and drug development. As with many small molecule inhibitors, its efficacy and specificity are critical parameters that are evaluated through various in vitro and in vivo studies. Overall, Galectin-8-IN-2 represents a promising avenue for therapeutic intervention in diseases where galectin-8 is a contributing factor.

Galectin-8-IN-2 (Compound 10) acts as an inhibitor of galectin-8N [1].

CAS 1044566-24-6

Galectin-8-IN-2

Galectin-8-IN-2

Ref: TM-T86490